Krsnaa Diagnostics

About Krsnaa Diagnostics

Krsnaa Diagnostics is a prominent diagnostic services provider in India, focusing on radiology, pathology, and teleradiology. The company was originally incorporated in Pune, Maharashtra, on December 22, 2010. It was founded by Rajendra Mutha with the vision of making quality diagnostic services accessible and affordable, particularly in non-metro and lower-tier cities.

The company's business model is centered around public-private partnerships (PPPs) with government hospitals, medical colleges, and community health centers. Under this model, Krsnaa Diagnostics sets up diagnostic centers within these public facilities, leveraging a captive patient base and minimizing rental and marketing costs. This strategy allows them to offer services at significantly lower prices—radiology tests are priced 45%-60% lower and pathology tests 40%-80% lower than average market rates. In addition to PPPs, the company serves private healthcare providers and is expanding its direct-to-consumer (B2C) retail presence through a franchise model.

Krsnaa Diagnostics offers a comprehensive range of services, including 1,394 radiology tests and 2,544 pathology tests. Its imaging services include MRI, CT scans, X-rays, and mammography, supported by a large teleradiology hub in Pune that can process high volumes of scans 24/7. The company operates an extensive network across India, with over 3,600 centers as of fiscal year 2024. A significant milestone was its Initial Public Offering (IPO) in August 2021, which raised over ₹1,213 crore to fund further expansion. The company continues to grow, with a recent strategic acquisition of a 23.53% stake in Apulki Healthcare to become its exclusive diagnostics partner for cancer and cardiac care hospitals.